Abstract
Medicinal science involves the study of pharmaca, especially of chemicals used in medicine as therapeutic and occasionally as prophylactic agents. It is based on combinations of experimental biology and chemistry and physics applied to the understanding of pathologies and restoring normal conditions in animal cells and tissues. The widest areas contributing to medicinal science are medicinal chemistry, biochemistry and pathology applied to metabolic aberrations, pharmacology, microbiology and virology, endocrinology and immunology. Many medical specialties funnel information into medicinal science and vice versa where pharmacotherapeutic treatment is involved. It would be a great advantage if unified concepts could be found to tie all these activities together. In physics and chemistry, the trend toward such generalizations is making progress. Biology and behavioral sciences are approaching the stage at which many of their phenomena are becoming classifiable as chemical and physical manifestations. But unified explanations in biology run into difficulties through refined visual observations and instrumental measurements. As we advance toward visualization of macromolecules by electron microscopy, X-ray diffractometry and other spectroscopic methods, we witness a centrifugal expansion of what had been thought to be ultimate biological entities only a few years ago. Where ‘animate’ matter and macromolecules meet we recognize the growing importance of molecular aggregation and polymerization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.J. Gordon and S. G. Gilgore, Progr. Drug Res. 16, 194 (1972).
For a review, see B.H. Takman and G. Camougis, in: Medicinal Chemistry, 3rd ed., chap. 20 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 1607 – 1632.
For a review, see R.M. Pinder, Malaria (Ed. Scientechnica, Ltd., Bristol, England, 1973 ).
G. Barger and H.H. Dale, J. Physiol., Lond., 41, 19 (1910/1911).
K.K. Chen and C.F. Schmidt, J. Pharmac. exp. Ther. 24, 339 (1924); K.K. Chen and C.F. Schmidt, Ephedrine and Related Substances (Williams & Wilkins, Baltimore, Md., 1930 ).
G.A. Alles, J. Pharmac. exp. Ther. 32, 121 (1927); 47, 339 (1933); G.A. Alles and M. Prinzmetal, ibid. 48, 161 (1933).
D.J. Triggle, in: Medicinal Chemistry, 3rd ed., chap. 46 (Ed. A. Burger; Wiley- Interscience, New York 1970 ), p. 1235–1295.
For a sketch of Ehrlich’s work, see A. Burger, Chem. Eng. News 32, 4172 (1954).
G. Domagk, Dt. med. Wschr. 61, 250 (1935).
J. Tréfouel, Mme, J. Tréfoufel, F. Nitti and D. Bovet, Compt. rend. Soc. Biol. 120, 756 (1935).
M. Tishler, Molecular Modification in Modern Drug Research, in: Advances in Chemistry Series 45, 1–14 ( American Chemical Society, Washington, D.C., 1964 ).
F. Schönhöfer, Z. physiol. Chem. 274, 1 (1942).
R. Seifert, J. Prakt. Chem. 31, 472 (1885); M. Nencki, Arch. exp. Path. Pharmakol. 20, 396 (1886); 36, 400 (1895).
E. Overton, Vierteljahrsschr. Naturforsch. Ges. Zürich 44, 88 (1899).
H. Meyer, Arch. exp. Path. Pharmakol. 42, 109 (1899).
H. Erlenmeyer and E. Berger, Biochem. Z. 252, 22 (1932); 255, 429 (1932); 262, 196 (1933).
H. Erlenmeyer, E. Berger and M. Leo, Helv. Chim. Acta 16, 733 (1933).
H. Erlenmeyer and M. Leo, ibid. 15, 1171 (1932); 16, 897, 1381 (1933).
H. Erlenmeyer and E. Willi, ibid. 18, 740 (1935).
H.L. Friedman, Influence of Isosteric Replacement upon Biological Activity, Nat. Acad. Sci. - Nat. Res. Council Publ. No. 206 ( Washington, D.C., 1951 ), p. 295.
A. Burger, in: Medicinal Chemistry, 3rd ed., chap. 6 (Ed. A. Burger; Wiley-Interscience, New York 1970 ), p. 72–80.
C. Hansch, Quantitative Structure-Activity Relationships in Drug Design, in: Drug Design, Vol.1, chap. 2 (Ed. E.J. Ariens; Academic Press, New York, London 1971 ), p. 271–342.
A. Leo, C. Hansch and D. Elkins, Chem. Rev. 71, 525 (1971); R.N. Smith, C. Hansch and M.M. Ames, J. Pharm. Sci. 64, 599 (1975).
A. P. Grollman, Proc. Nat. Acad. Sci. US 56, 1867 (1966).
B. R. Baker, Design of Active-Site-Directed Enzyme Inhibitors ( Wiley, New York 1964 ).
B.R. Baker, in: Medicinal Chemistry, 3rd ed., chap. 12 (Ed. A. Burger; Wiley- Interscience, New York 1970 ), p. 196–228.
R.J.B. King and W.I.P. Mainwaring, Steroid-Cell Interactions ( University Park Press, Baltimore, Md., 1974 ), p. 202–228.
J.S. Pierce, in: Medicinal Chemistry, 2nd ed., chap. 21 (Ed. A. Burger; Interscience, New York 1960 ), p. 463–493.
D.T. Witiak, in: Medicinal Chemistry, 3rd ed., chap. 65 (Ed. A. Burger; Wiley- Interscience, New York 1970 ), p. 1643–1668.
Annual Reports in Medicinal Chemistry. Sponsored by the Division of Medicinal Chemistry of the American Chemical Society (Academic Press, New York, London). Issued annually. Vol. 10 (1975) was edited by R. V. Heinzelman.
Progress in Medicinal Chemistry (Eds. G.P. Ellis and G.B. West; Appleton-Century- Crofts, New York). Issued semiannually.
Advances in Drug Research (Eds. N.J. Harper and A.B. Simmonds; Academic Press, New York, London).
Medicinal Chemistry (Ed. G. de Stevens; Academic Press, New York, London 1963 ).
Topics in Medicinal Chemistry (Eds. J.L. Rabinowitz and R.M. Myerson; Wiley- Interscience, New York).
Medicinal Research (edited by G. Grunewald [Vols. 1–3 edited by A. Burger]; Dekker, New York).
Ann. Rev. Pharmacol, Annual Reviews, Inc., Palo Alto, California (issued annually).
W. W. Wardell, Clin. Pharmac. Ther. 15, 73 (1974).
Report for 1971, Her Majesty’s Stationery Office, London 1972.
D. Dunlop, The Regulation of the Introduction of New Pharmaceuticals (Center for Policy Study, University of Chicago, 1972 ).
S. Peltzman (Center for Policy Study, University of Chicago, 1970 ).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Birkhäuser Verlag, Basel
About this chapter
Cite this chapter
Burger, A. (1976). The State of Medicinal Science. In: Jucker, E. (eds) Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrés des recherches pharmaceutiques. Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrés des recherches pharmaceutiques, vol 20. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7094-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7094-8_1
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7096-2
Online ISBN: 978-3-0348-7094-8
eBook Packages: Springer Book Archive